← boothcheck

Is ACHC overvalued?

boothcheck doesn't label ACHC overvalued or undervalued, and it doesn't publish a fair value. It shows what the price assumes instead. The price is justified by relative-multiple. The more the price assumes beyond what Acadia Healthcare Company, Inc. has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from Acadia Healthcare Company, Inc.'s SEC EDGAR filings via a reverse-DCF inversion. Last analyzed June 27, 2026.

Implied growth
For about
Margin needed
Margin today
Price vs asset value1.48x
Price vs peer multiples0.33x
Read the full ACHC report →
Get boothcheck's read on what ACHC's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.